Capsule dosage form of metoprolol succinate
US9504655B2 · kind B2 · utility
2Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2016 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Feb 1, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an extended-release capsule dosage form of metoprolol succinate in the form of coated discrete units and processes for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.